Mycoplasma genitalium (Mgen)
People receiving treatment for Mgen should take all of the medication as prescribed.
Mgen is a drug-resistant germ CDC and other health experts are closely monitoring.
Mgen can usually be cured with antibiotics.
Mycoplasma genitalium (Mgen) Treatment Failure Registry – Healthcare providers and health departments can report Mgen treatment failures to the CDC. (December 12, 2022)
- Prevalence of Urogenital Mycoplasma genitalium Infection, United States, 2017 to 2018 – During the 2017–2018 National Health and Nutrition Examination Survey, the estimated prevalence of urogenital Mgen infection was 1.7% among 14- to 59-year-olds in the United States. (November 1, 2021)
- 2021 STI Treatment Guidelines – Mycoplasma genitalium – Describes the association of Mycoplasma genitalium with urethritis and cervicitis, as well as diagnostic considerations and treatment implications. (July 22, 2021)
- Antibiotic Resistance Threats in the United States, 2019 – Drug-resistant Mycoplasma genitalium is on CDC’s Watch List. (November 13, 2019)